Abivax reports H1 2026 results; appoints new CMO and CTO
Abivax SA reported first-half 2026 results and named Chris Rabbat as CMO and Tim Kelly as CTO as it advances toward potential commercialization of obefazimod.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.